Trademark: 79311185
Status Date
Tuesday, August 30, 2022
Registration Number
6829674
Registration Date
Tuesday, August 30, 2022
Filing Date
Friday, February 26, 2021
Published for Opposition
Tuesday, June 14, 2022
5 Pharmaceutical preparations and substances for use in gene therapy, namely, for treatment of sickle cell disease
The wording "HEMJENA" has no meaning in a foreign language.
Dec 23, 2023
Change Of Name/Address Rec'd From Ib
Jan 3, 2023
Final Decision Transaction Processed By Ib
Dec 9, 2022
Final Disposition Notice Sent To Ib
Dec 8, 2022
Final Disposition Processed
Nov 30, 2022
Final Disposition Notice Created, To Be Sent To Ib
Aug 30, 2022
Notice Of Registration Confirmation Emailed
Aug 30, 2022
Registered-Principal Register
Aug 26, 2022
Change Of Name/Address Rec'd From Ib
Jun 14, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 14, 2022
Published For Opposition
May 25, 2022
Notification Of Notice Of Publication E-Mailed
May 8, 2022
Approved For Pub - Principal Register
Mar 31, 2022
Teas/Email Correspondence Entered
Mar 31, 2022
Correspondence Received In Law Office
Mar 31, 2022
Teas Response To Office Action Received
Dec 18, 2021
New Representative At Ib Received
Nov 6, 2021
Change Of Owner Received From Ib
Oct 30, 2021
Refusal Processed By Ib
Oct 4, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Oct 4, 2021
Refusal Processed By Mpu
Sep 22, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Sep 21, 2021
Non-Final Action Written
Sep 21, 2021
Assigned To Examiner
May 25, 2021
Application Filing Receipt Mailed
May 21, 2021
New Application Office Supplied Data Entered
May 20, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
